Valeant Pharmaceuticals International Inc (TSE:VRX) - Share price - Overview

Stock Report

Valeant Pharmaceuticals International Inc VRX

Last Price
CAD21.20

Day Change
-0.54|-2.48%

As of 24/02/2017
16:00:00 EST | CAD
Minimum 15 Minutes Delay.

Last Close21.74
Day Range21.09 - 21.59
Mkt Cap7.37Bil
52-Wk Range17.19 - 117.03
Yield %-
ISINCA91911K1021
Volume840,029
P/E-
P/S0.56
P/CF2.65

Share Price

Financials
201320142015
More ...
Income Statement
Revenue5,769.618,263.5010,446.50
Operating Income-409.502,039.701,527.40
Net Income-866.14913.50-291.70
Basic EPS-2.702.72-0.85
Avg. Diluted Shares Outstanding321342343
Balance Sheet
Current Assets3,885.894,193.105,507.20
Non Current Assets24,084.9122,159.9043,457.30
Total Assets27,970.8026,353.0048,964.50
Current Liabilities2,512.402,730.805,312.60
Total Liabilities22,852.0721,040.8043,053.50
Total Equity5,118.725,312.205,911.00
Cash Flow
Operating Cash Flow1,041.962,294.702,200.40
Capital Expenditure-184.96-470.60-303.30
Free Cash Flow857.001,824.101,897.10

In millions, except "Basic EPS". Currency is USD.

Company Profile

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company that develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Mid-Value

Fiscal Year Ends

December

Employees

22,000
Key Stats
More ...
Price/Earning TTM-
Price/Book1.38
Price/Sales TTM-
Rev Growth (3 year avg)43.35
EPS Growth (3 year avg)-
Operating Margin % TTM14.62
Net Margin % TTM-2.79
ROE TTM-5.20
Debt/Equity5.12
Dividends
PreviousLatest
More ...
Declared Date06/08/1005/11/10
Ex-Div30/08/1010/11/10
Paid04/10/1022/12/10
Amnt0.101.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.